CSPC innovation pharma ups stake in Jushi bio-pharmaceutical to 80%

CSPC Innovation Pharmaceutical announced the successful completion of the industrial and commercial change registration for its acquisition of a 29% equity interest in CSPC Group Jushi Bio-Pharmaceutical Co., Ltd. This transaction was approved by the board of directors on September 30, 2025, and shareholders on October 16, 2025.

The acquisition involved a cash payment of 1.1 billion yuan for the 29% stake, purchased from CSPC Group Enbipu Pharmaceutical Co., Ltd. Following this transaction, CSPC Innovation Pharmaceutical's ownership in Jushi Bio-Pharmaceutical has increased from 51% to 80%.

Before the change, CSPC Group Enbipu Pharmaceutical Co., Ltd. held a 49% stake, while CSPC Innovation Pharmaceutical held 51%. Post-registration, CSPC Group Enbipu Pharmaceutical Co., Ltd.'s holding is now 20%, and CSPC Innovation Pharmaceutical holds 80%.